AIM: To evaluate several risk factors for gastric cancer (GC) in Costa Rican regions with contrasting GC incidence rate (GCIR). METHODS: According to GCIR, 191 Helicobacter pylori (H pylori)-positive patients were classified into groups A (high GCIR, n = 101) and B (low GCIR, n = 90). Human DNA obtained from biopsy specimens was used in the determination of polymorphisms of the genes coding for interleukin (IL)-1beta and IL-10 by PCR-RFLP, and IL-1RN by PCR. H pylori DNA extractions obtained from clinical isolates of 83 patients were used for PCR-based genotyping of H pylori cagA, vacA and babA2. Human DNA from gastric biopsies of 52 GC patients was utilized for comparative purposes. RESULTS: Cytokine polymorphisms showed no association with GCIR variability. However, gastric atrophy, intestinal metaplasia and strains with different vacA genotypes in the same stomach (mixed strain infection) were more frequently found in group A than in group B, and cagA and vacA s1b were significantly associated with high GCIR (P = 0.026 and 0.041, respectively). IL-1beta+3954_T/C (OR 2.1, 1.0-4.3), IL-1RN*2/L (OR 3.5, 1.7-7.3) and IL-10-592_C/A (OR 3.2, 1.5-6.8) were individually associated with GC, and a combination of these cytokine polymorphisms with H pylori vacA s1b and m1 further increased the risk (OR 7.2, 1.4-36.4). CONCLUSION: Although a proinflammatory cytokine genetic profile showed an increased risk for developing GC, the characteristics of H pylori infection, in particular the status of cagA and vacA genotype distribution seemed to play a major role in GCIR variability in Costa Rica.
AIM: To evaluate several risk factors for gastric cancer (GC) in Costa Rican regions with contrasting GC incidence rate (GCIR). METHODS: According to GCIR, 191 Helicobacter pylori (H pylori)-positive patients were classified into groups A (high GCIR, n = 101) and B (low GCIR, n = 90). Human DNA obtained from biopsy specimens was used in the determination of polymorphisms of the genes coding for interleukin (IL)-1beta and IL-10 by PCR-RFLP, and IL-1RN by PCR. H pylori DNA extractions obtained from clinical isolates of 83 patients were used for PCR-based genotyping of H pylori cagA, vacA and babA2. Human DNA from gastric biopsies of 52 GC patients was utilized for comparative purposes. RESULTS: Cytokine polymorphisms showed no association with GCIR variability. However, gastric atrophy, intestinal metaplasia and strains with different vacA genotypes in the same stomach (mixed strain infection) were more frequently found in group A than in group B, and cagA and vacA s1b were significantly associated with high GCIR (P = 0.026 and 0.041, respectively). IL-1beta+3954_T/C (OR 2.1, 1.0-4.3), IL-1RN*2/L (OR 3.5, 1.7-7.3) and IL-10-592_C/A (OR 3.2, 1.5-6.8) were individually associated with GC, and a combination of these cytokine polymorphisms with H pylori vacA s1b and m1 further increased the risk (OR 7.2, 1.4-36.4). CONCLUSION: Although a proinflammatory cytokine genetic profile showed an increased risk for developing GC, the characteristics of H pylori infection, in particular the status of cagA and vacA genotype distribution seemed to play a major role in GCIR variability in Costa Rica.
Authors: Abdussalam A R Ashour; Paula P Magalhães; Edilberto N Mendes; Guilherme B Collares; Valquíria R de Gusmão; Dulciene M M Queiroz; Ana Margarida M F Nogueira; Gifone A Rocha; Celso A de Oliveira Journal: FEMS Immunol Med Microbiol Date: 2002-07-12
Authors: M Gerhard; N Lehn; N Neumayer; T Borén; R Rad; W Schepp; S Miehlke; M Classen; C Prinz Journal: Proc Natl Acad Sci U S A Date: 1999-10-26 Impact factor: 11.205
Authors: C-F Zambon; D Basso; F Navaglia; G Germano; N Gallo; M Milazzo; E Greco; P Fogar; S Mazza; F Di Mario; G Basso; M Rugge; M Plebani Journal: Cytokine Date: 2002-06-07 Impact factor: 3.861
Authors: Céu Figueiredo; José Carlos Machado; Paul Pharoah; Raquel Seruca; Sónia Sousa; Ralph Carvalho; Ana Filipa Capelinha; Wim Quint; Carlos Caldas; Leen-Jan van Doorn; Fátima Carneiro; Manuel Sobrinho-Simões Journal: J Natl Cancer Inst Date: 2002-11-20 Impact factor: 13.506
Authors: Sergio A Con; Reinaldo Con-Wong; Gil R Con-Chin; Vicky G Con-Chin; Hiroaki Takeuchi; Ana L Valerín; Guillermo Echandi; Fernando Mena; Fernando Brenes; Nobufumi Yasuda; Keijiro Araki; Tetsuro Sugiura Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-12 Impact factor: 4.254
Authors: Patricia Bonequi; Fernando Meneses-González; Pelayo Correa; Charles S Rabkin; M Constanza Camargo Journal: Cancer Causes Control Date: 2012-12-07 Impact factor: 2.506
Authors: Ricardo L Dominguez; Seth D Crockett; Jennifer L Lund; Lia P Suazo; Paris Heidt; Christopher Martin; Douglas R Morgan Journal: Cancer Causes Control Date: 2012-12-22 Impact factor: 2.506
Authors: Camila A Figueiredo; Cintia Rodrigues Marques; Ryan dos Santos Costa; Hugo Bernardino F da Silva; Neuza M Alcantara-Neves Journal: World J Gastroenterol Date: 2014-05-14 Impact factor: 5.742